Deutsche Bank’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $22.2K | Buy |
|
|||||
|
2022
Q4 | $21.3K | Buy |
|
|||||
|
2022
Q3 | $134K | Sell |
|
|||||
|
2022
Q2 | $129K | Buy |
|
|||||
|
2022
Q1 | $144K | Sell |
|
|||||
|
2021
Q4 | $101K | Buy |
|
|||||
|
2021
Q3 | $123K | Sell |
|
|||||
|
2021
Q2 | $162K | Sell |
|
|||||
|
2021
Q1 | $187K | Sell |
|
|||||
|
2020
Q4 | $284K | Buy |
|
|||||
|
2020
Q3 | $125K | Buy |
|
|||||
|
2020
Q2 | $111K | Sell |
|
|||||
|
2020
Q1 | $358K | Buy |
|
|||||
|
2019
Q4 | $192K | Buy |
|
|||||
|
2019
Q3 | $67K | Sell |
|
|||||
|
2019
Q2 | $293K | Sell |
|
|||||
|
2019
Q1 | $412K | Sell |
|
|||||
|
2018
Q4 | $443K | Sell |
|
|||||
|
2018
Q3 | $655K | Sell |
|
|||||
|
2018
Q2 | $701K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $162K | Sell |
|
|||||
|
2017
Q3 | $1.01M | Buy |
|
|||||
|
2017
Q2 | $395K | Buy |
|
|||||
|
2017
Q1 | $458K | Sell |
|
|||||
|
2016
Q4 | $474K | Buy |
|
|||||
|
2016
Q3 | $369K | Sell |
|
|||||
|
2016
Q2 | $627K | Buy |
|
|||||
|
2016
Q1 | $273K | Sell |
|
|||||
|
2015
Q4 | $395K | Buy |
|
|||||
|
2015
Q3 | $6K | Buy |
|
|||||
|
2015
Q2 | $6K | Sell |
|
|||||
|
2015
Q1 | $2.33M | Buy |
|
|||||
|
2014
Q4 | $375K | Buy |
|
|||||
|
2014
Q3 | $94K | Sell |
|
|||||
|
2014
Q2 | $148K | Buy |
|
|||||
|
2014
Q1 | $18K | Buy |
|